COST-EFFECTIVENESS ANALYSIS OF THE EARLY CONVERSION OF TACROLIMUS TO MTOR INHIBITORS IN PATIENTS WITH RENAL TRANSPLANTATION

被引：0
|
作者：
Gamboa, O. [1 ]
Montero, C. [2 ]
Mesa, L. [3 ]
Benavides, C. [4 ]
Reino, A. [5 ]
Castillo, J. S. [6 ]
机构：
[1] Fdn Esensa, Bogota, Colombia
[2] Clin Univ Colombia, Bogota, Colombia
[3] Fdn Valle Lili, Cali, Colombia
[4] Fdn CardioInfantil, Bogota, Colombia
[5] Hosp San Vicente de Paul, Medellin, Colombia
[6] IECAS, Bogota, Colombia
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 03期
关键词：
D O I：
10.1016/j.jval.2011.02.428
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
下载
收藏
页码：A76 / A76
页数：1
相关论文
共 50 条
  • [21] Cost-effectiveness of modern mTOR inhibitor based immunosuppression compared to the standard of care after renal transplantation in Germany
    Juergensen, Jan Steffen
    Ikenberg, Robert
    Greiner, Roger-Axel
    Hoesel, Volker
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2015, 16 (04): : 377 - 390
  • [22] Cost-effectiveness of modern mTOR inhibitor based immunosuppression compared to the standard of care after renal transplantation in Germany
    Jan Steffen Jürgensen
    Robert Ikenberg
    Roger-Axel Greiner
    Volker Hösel
    The European Journal of Health Economics, 2015, 16 : 377 - 390
  • [23] Diagnostic Workup for Patients with Solid Renal Masses: A Cost-Effectiveness Analysis
    Runtemund, Jasmin
    Ruebenthaler, Johannes
    von Muenchhausen, Niklas
    Ingenerf, Maria
    Grawe, Freba
    Biechele, Gloria
    Gassert, Felix Gerhard
    Tollens, Fabian
    Rink, Johann
    Cecatka, Sasa
    Schmid-Tannwald, Christine
    Froelich, Matthias F.
    Clevert, Dirk-Andre
    Schnitzer, Moritz L.
    CANCERS, 2022, 14 (09)
  • [24] Cost-effectiveness analysis of immunosuppressive drugs in post-renal transplantation maintenance therapy in adult patients in Brazil
    Acurcio, Francisco de Assis
    Mattana Saturnino, Luciana Tarbes
    da Silva, Anderson Lourenco
    Araujo de Oliveira, Gustavo Laine
    Gurgel Andrade, Eli Iola
    Cherchiglia, Mariangela Leal
    Braga Ceccato, Maria das Gracas
    CADERNOS DE SAUDE PUBLICA, 2013, 29 : S92 - S109
  • [25] COST-EFFECTIVENESS ANALYSIS OF MYOSTRAIN IN THE EARLY DETECTION OF HEART FAILURE PATIENTS
    Stojanovic, I
    Schneider, J. E.
    VALUE IN HEALTH, 2018, 21 : S216 - S216
  • [26] EMICIZUMAB PROPHYLAXIS IN HAEMOPHILIA A PATIENTS WITH INHIBITORS: A COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS
    Cortesi, P. A.
    Castaman, G.
    Trifiro, G.
    Ferrario, M.
    Improta, G.
    Mazzaglia, G.
    Molinari, A. C.
    Mantovani, L. G.
    VALUE IN HEALTH, 2019, 22 : S845 - S845
  • [27] Immune tolerance induction for hemophilia A patients with inhibitors: A cost-effectiveness analysis.
    Colowick, AB
    Bohn, R
    Avorn, JL
    Ewenstein, BM
    BLOOD, 1998, 92 (10) : 553A - 553A
  • [28] Effectiveness and cost-effectiveness of early screening and treatment of malnourished patients
    Kruizenga, HM
    Van Tulder, MW
    Seidell, JC
    Thijs, A
    Ader, HJ
    van der Schueren, MAEV
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2005, 82 (05): : 1082 - 1089
  • [29] Is There a Role for mTOR Inhibitors in Renal Transplantation?
    Zaltzman, Jeffrey Steven
    TRANSPLANTATION, 2017, 101 (02) : 228 - 229
  • [30] Fecal microbiota transplantation for patients with active ulcerative colitis: A cost-effectiveness analysis
    Yao, Jiaqi
    Fekadu, Ginenus
    Ng, Siew C.
    You, Joyce H. S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 (01) : 70 - 78
12345